Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Temporal virus serological profiling of kidney graft recipients using VirScan.

Isnard P, Kula T, Avettand Fenoel V, Anglicheau D, Terzi F, Legendre C, Elledge SJ, Canaud G.

Proc Natl Acad Sci U S A. 2019 May 28;116(22):10899-10904. doi: 10.1073/pnas.1821166116. Epub 2019 May 13.

PMID:
31085644
2.

Membranous Nephropathy Post-Transplantation: An Update of the Pathophysiology and Management.

Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV.

Transplantation. 2019 Apr 10. doi: 10.1097/TP.0000000000002758. [Epub ahead of print]

PMID:
30985736
3.

Author Correction: Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2019 Apr;568(7752):E6. doi: 10.1038/s41586-019-1109-3.

PMID:
30944482
4.

Cyclin G1 and TASCC regulate kidney epithelial cell G2-M arrest and fibrotic maladaptive repair.

Canaud G, Brooks CR, Kishi S, Taguchi K, Nishimura K, Magassa S, Scott A, Hsiao LL, Ichimura T, Terzi F, Yang L, Bonventre JV.

Sci Transl Med. 2019 Jan 23;11(476). pii: eaav4754. doi: 10.1126/scitranslmed.aav4754.

PMID:
30674655
5.

mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.

Johnson SC, Martinez F, Bitto A, Gonzalez B, Tazaerslan C, Cohen C, Delaval L, Timsit J, Knebelmann B, Terzi F, Mahal T, Zhu Y, Morgan PG, Sedensky MM, Kaeberlein M, Legendre C, Suh Y, Canaud G.

Kidney Int. 2019 Feb;95(2):455-466. doi: 10.1016/j.kint.2018.08.038. Epub 2018 Nov 22.

PMID:
30471880
6.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Arrestier R, Satie AP, Zhang SY, Plaisier E, Isnard-Bagnis C, Gatault P, Raimbourg Q, Buob D, Vocila F, Heng AE, Francois H, Moktefi A, Canaud G, Matignon M, Dejucq-Rainsford N, Brocheriou I, Sahali D, Audard V.

BMC Nephrol. 2018 Nov 20;19(1):331. doi: 10.1186/s12882-018-1132-x.

7.

Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, Blanc E, Johnson SC, Hoguin C, Boccara O, Sarnacki S, Boddaert N, Pannier S, Martinez F, Magassa S, Yamaguchi J, Knebelmann B, Merville P, Grenier N, Joly D, Cormier-Daire V, Michot C, Bole-Feysot C, Picard A, Soupre V, Lyonnet S, Sadoine J, Slimani L, Chaussain C, Laroche-Raynaud C, Guibaud L, Broissand C, Amiel J, Legendre C, Terzi F, Canaud G.

Nature. 2018 Jun;558(7711):540-546. doi: 10.1038/s41586-018-0217-9. Epub 2018 Jun 13. Erratum in: Nature. 2019 Apr;568(7752):E6.

PMID:
29899452
8.

FSGS ACTH Gel: Part of the Answer?

Delville M, Canaud G, Legendre C.

Transplantation. 2019 Jan;103(1):15-16. doi: 10.1097/TP.0000000000002321. No abstract available.

PMID:
29894412
9.

Vascular endothelial growth factor backfiltration in the glomerulus: an intriguing mechanism.

Yamaguchi J, Canaud G.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1483-1484. doi: 10.1093/ndt/gfy114. No abstract available.

PMID:
29718406
10.

mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G.

Hadjadj J, Canaud G, Mirault T, Samson M, Bruneval P, Régent A, Goulvestre C, Witko-Sarsat V, Costedoat-Chalumeau N, Guillevin L, Mouthon L, Terrier B; French Vasculitis Study Group.

Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017.

PMID:
29506143
11.

Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey.

Gauthier M, Canoui-Poitrine F, Guéry E, Desvaux D, Hue S, Canaud G, Stehle T, Lang P, Kofman T, Grimbert P, Matignon M.

Nephrol Dial Transplant. 2018 Apr 1;33(4):709-716. doi: 10.1093/ndt/gfx353.

PMID:
29346631
12.

Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Siddique S, Risse J, Canaud G, Zuily S.

Curr Rheumatol Rep. 2017 Sep 4;19(10):64. doi: 10.1007/s11926-017-0687-z. Review.

PMID:
28871481
13.

[PIK3CA-related overgrowth syndrome (PROS)].

Venot Q, Canaud G.

Nephrol Ther. 2017 Apr;13 Suppl 1:S155-S156. doi: 10.1016/j.nephro.2017.02.004. Review. French.

PMID:
28577738
14.

HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation.

Avettand-Fenoël V, Rouzioux C, Legendre C, Canaud G.

Transplantation. 2017 Sep;101(9):2003-2008. doi: 10.1097/TP.0000000000001674. Review.

PMID:
28196049
15.

Antiphospholipid syndrome and kidney disease.

Bienaimé F, Legendre C, Terzi F, Canaud G.

Kidney Int. 2017 Jan;91(1):34-44. doi: 10.1016/j.kint.2016.06.026. Epub 2016 Aug 21. Review.

PMID:
27555120
16.

The costimulatory receptor B7-1 is not induced in injured podocytes.

Baye E, Gallazzini M, Delville M, Legendre C, Terzi F, Canaud G.

Kidney Int. 2016 Nov;90(5):1037-1044. doi: 10.1016/j.kint.2016.06.022. Epub 2016 Aug 12.

17.

Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.

Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.

Transplantation. 2017 Mar;101(3):649-656. doi: 10.1097/TP.0000000000001160.

PMID:
27043407
18.

Molecular pathways of chronic kidney disease progression.

Bienaimé F, Canaud G, El Karoui K, Gallazzini M, Terzi F.

Nephrol Ther. 2016 Apr;12 Suppl 1:S35-8. doi: 10.1016/j.nephro.2016.02.009. Epub 2016 Mar 10. Review.

PMID:
26972095
19.

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G.

J Am Soc Nephrol. 2016 Aug;27(8):2520-7. doi: 10.1681/ASN.2015091002. Epub 2015 Dec 23.

20.

Focal Segmental Glomerulosclerosis Recurrence: Soluble Urokinase Receptor Left Out?

Canaud G, Loupy A.

Transplantation. 2015 Dec;99(12):2449-50. doi: 10.1097/TP.0000000000000923. No abstract available.

PMID:
26371599
21.

Recurrence of Focal and Segmental Glomerulosclerosis After Transplantation.

Canaud G, Delville M, Legendre C.

Transplantation. 2016 Feb;100(2):284-7. doi: 10.1097/TP.0000000000000902. Review.

PMID:
26247557
22.

HIV-positive-to-HIV-positive kidney transplantation.

Canaud G, Avettand-Fenoel V, Legendre C.

N Engl J Med. 2015 May 21;372(21):2069. doi: 10.1056/NEJMc1503288. No abstract available.

PMID:
25992754
23.

[New insights in the antiphospholipid syndrome associated vasculitis: the role of the AKT/mTORC pathway].

Canaud G.

Rev Med Interne. 2015 Jul;36(7):439-43. doi: 10.1016/j.revmed.2015.02.006. Epub 2015 Mar 11. French. No abstract available.

PMID:
25769629
24.

AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game.

Canaud G, Legendre C, Terzi F.

Lupus. 2015 Mar;24(3):227-30. doi: 10.1177/0961203315569336. Epub 2015 Jan 27. No abstract available.

PMID:
25631854
25.

Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Canaud G, Terzi F.

N Engl J Med. 2014 Oct 16;371(16):1554-5. doi: 10.1056/NEJMc1410247. No abstract available.

PMID:
25317877
26.

Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerová D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Pączek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG.

Nat Genet. 2014 Nov;46(11):1187-96. doi: 10.1038/ng.3118. Epub 2014 Oct 12.

27.

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, Burke GW, Bruneval P, Naesens M, Jackson A, Alachkar N, Canaud G, Legendre C, Anglicheau D, Reiser J, Sarwal MM.

Sci Transl Med. 2014 Oct 1;6(256):256ra136. doi: 10.1126/scitranslmed.3008538.

28.

Inhibition of the mTORC pathway in the antiphospholipid syndrome.

Canaud G, Bienaimé F, Tabarin F, Bataillon G, Seilhean D, Noël LH, Dragon-Durey MA, Snanoudj R, Friedlander G, Halbwachs-Mecarelli L, Legendre C, Terzi F.

N Engl J Med. 2014 Jul 24;371(4):303-12. doi: 10.1056/NEJMoa1312890.

29.

Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury.

Canaud G, Bonventre JV.

Nephrol Dial Transplant. 2015 Apr;30(4):575-83. doi: 10.1093/ndt/gfu230. Epub 2014 Jul 12. Review.

30.

V-ATPase/mTOR signaling regulates megalin-mediated apical endocytosis.

Gleixner EM, Canaud G, Hermle T, Guida MC, Kretz O, Helmstädter M, Huber TB, Eimer S, Terzi F, Simons M.

Cell Rep. 2014 Jul 10;8(1):10-9. doi: 10.1016/j.celrep.2014.05.035. Epub 2014 Jun 19.

31.

A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS.

Huynh Cong E, Bizet AA, Boyer O, Woerner S, Gribouval O, Filhol E, Arrondel C, Thomas S, Silbermann F, Canaud G, Hachicha J, Ben Dhia N, Peraldi MN, Harzallah K, Iftene D, Daniel L, Willems M, Noel LH, Bole-Feysot C, Nitschké P, Gubler MC, Mollet G, Saunier S, Antignac C.

J Am Soc Nephrol. 2014 Nov;25(11):2435-43. doi: 10.1681/ASN.2013101126. Epub 2014 May 29.

32.

The kidney as a reservoir for HIV-1 after renal transplantation.

Canaud G, Dejucq-Rainsford N, Avettand-Fenoël V, Viard JP, Anglicheau D, Bienaimé F, Muorah M, Galmiche L, Gribouval O, Noël LH, Satie AP, Martinez F, Sberro-Soussan R, Scemla A, Gubler MC, Friedlander G, Antignac C, Timsit MO, Onetti Muda A, Terzi F, Rouzioux C, Legendre C.

J Am Soc Nephrol. 2014 Feb;25(2):407-19. doi: 10.1681/ASN.2013050564. Epub 2013 Dec 5.

33.

Factors influencing long-term outcome after kidney transplantation.

Legendre C, Canaud G, Martinez F.

Transpl Int. 2014 Jan;27(1):19-27. doi: 10.1111/tri.12217. Epub 2013 Nov 8. Review.

34.

AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.

Canaud G, Bienaimé F, Viau A, Treins C, Baron W, Nguyen C, Burtin M, Berissi S, Giannakakis K, Muda AO, Zschiedrich S, Huber TB, Friedlander G, Legendre C, Pontoglio M, Pende M, Terzi F.

Nat Med. 2013 Oct;19(10):1288-96. doi: 10.1038/nm.3313. Epub 2013 Sep 22.

PMID:
24056770
35.

Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes.

Canaud G, Kamar N, Anglicheau D, Esposito L, Rabant M, Noël LH, Guilbeau-Frugier C, Sberro-Soussan R, Del Bello A, Martinez F, Zuber J, Rostaing L, Legendre C.

Am J Transplant. 2013 Aug;13(8):2179-85. doi: 10.1111/ajt.12319. Epub 2013 Jun 13.

36.

Vitamin D status and outcomes after renal transplantation.

Bienaimé F, Girard D, Anglicheau D, Canaud G, Souberbielle JC, Kreis H, Noël LH, Friedlander G, Elie C, Legendre C, Prié D.

J Am Soc Nephrol. 2013 Apr;24(5):831-41. doi: 10.1681/ASN.2012060614. Epub 2013 Mar 28.

37.

Recurrence from primary and secondary glomerulopathy after renal transplant.

Canaud G, Audard V, Kofman T, Lang P, Legendre C, Grimbert P.

Transpl Int. 2012 Aug;25(8):812-24. doi: 10.1111/j.1432-2277.2012.01483.x. Epub 2012 Apr 16. Review.

38.

[Kidney allograft: a target for systemic disease].

Canaud G, Legendre C.

Presse Med. 2012 Mar;41(3 Pt 1):311-7. doi: 10.1016/j.lpm.2011.11.012. Epub 2012 Jan 13. Review. French.

PMID:
22244721
39.

INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.

Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, Huynh Cong E, Arrondel C, Tête MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G.

N Engl J Med. 2011 Dec 22;365(25):2377-88. doi: 10.1056/NEJMoa1109122.

40.

[Immunosuppressive treatments: mechanisms of action and clinical use].

Thervet E, Zuber J, Sberro R, Canaud G, Anglicheau D, Snanoudj R, Mamzer-Bruneel MF, Martinez F, Legendre C.

Nephrol Ther. 2011 Dec;7(7):566-81. doi: 10.1016/j.nephro.2010.12.008. Epub 2011 Jan 26. French.

PMID:
21273149
41.

Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies.

Canaud G, Bienaimé F, Noël LH, Royal V, Alyanakian MA, Dautzenberg MD, Rabant M, Posson J, Thervet E, Anglicheau D, Kreis H, Martinez F, Legendre C, Zuber J.

Am J Transplant. 2010 Sep;10(9):2051-60. doi: 10.1111/j.1600-6143.2010.03233.x.

42.

Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?

Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaimé F, Thervet E, Martinez F, Terzi F, Legendre C.

Am J Transplant. 2010 Jul;10(7):1701-6. doi: 10.1111/j.1600-6143.2010.03152.x.

43.

Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients.

Canaud G, Martinez F, Noël LH, Mamzer MF, Niaudet P, Legendre C.

Transplant Rev (Orlando). 2010 Jul;24(3):121-8. doi: 10.1016/j.trre.2010.04.001. Review.

PMID:
20537521
44.

Kidney transplantation at Necker Hospital: the most recent 5-year period (2004-2009).

Legendre Ch, Kreis H, Martinez F, Snanoudj R, Mamzer MF, Sberro R, Bererhi L, Anglicheau D, Zuber J, Loupy A, Thervet E, Pallet N, Sartorius A, Bertrand D, Canaud G, Noël LH, Rabant M, Timsit MO, Méjean A.

Clin Transpl. 2010:127-32.

PMID:
21696035
45.

Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries.

Canaud G, Bruneval P, Noël LH, Correas JM, Audard V, Zafrani L, Rabant M, Timsit MO, Martinez F, Anglicheau D, Thervet E, Patey N, Legendre C, Zuber J.

Am J Kidney Dis. 2010 Mar;55(3):558-65. doi: 10.1053/j.ajkd.2009.07.014. Epub 2009 Oct 2.

PMID:
19800721
46.

Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).

Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, Snanoudj R, Charbit M, Salomon R, Martinez F, Legendre C, Noel LH, Niaudet P.

Nephrol Dial Transplant. 2010 Apr;25(4):1321-8. doi: 10.1093/ndt/gfp500. Epub 2009 Sep 22.

PMID:
19773419
47.

HNF1B-related diabetes triggered by renal transplantation.

Zuber J, Bellanné-Chantelot C, Carette C, Canaud G, Gobrecht S, Gaha K, Mallet V, Martinez F, Thervet E, Timsit J, Legendre C, Dubois-Laforgue D.

Nat Rev Nephrol. 2009 Aug;5(8):480-4. doi: 10.1038/nrneph.2009.98.

PMID:
19639018
48.

Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study.

Canaud G, Zuber J, Sberro R, Royale V, Anglicheau D, Snanoudj R, Gaha K, Thervet E, Lefrère F, Cavazzana-Calvo M, Noël LH, Méjean A, Legendre Ch, Martinez F.

Am J Transplant. 2009 May;9(5):1081-6. doi: 10.1111/j.1600-6143.2009.02580.x. Epub 2009 Mar 16.

49.

Clinical challenges and images in GI. Esophageal mucosa expulsion after high-dose chemotherapy.

Canaud G, Vasiliu V, Suarez F.

Gastroenterology. 2009 May;136(5):1508, 1847. doi: 10.1053/j.gastro.2009.01.076. Epub 2009 Mar 17. No abstract available.

PMID:
19303022
50.

Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy.

Canaud G, Timsit MO, Zuber J, Bougnoux ME, Méjean A, Thervet E, Snanoudj R, Sberro R, Martinez F, Legendre C, Mamzer-Bruneel MF.

Nephrol Dial Transplant. 2009 Apr;24(4):1325-7. doi: 10.1093/ndt/gfn622. Epub 2008 Nov 11.

PMID:
19004850

Supplemental Content

Loading ...
Support Center